not losing weight with glp 1 5 Reasons You Aren't on Ozempic This is why you’re not

It is not yet approved by the FDA or Health Canada, but early clinical trial data has generated significant excitement

Tirzepatide has been studied extensively through the SURPASS trial program, generating a large dataset on receptor activity, glycemic markers, and body-weight-related endpoints in study populations

The product is not a substitute for a varied and balanced diet and a healthy lifestyle

Upregulated glycolysis could lead to immune activation with altered antibody production, lower self-tolerance, and increased cytokine release, resulting in transcriptional and post-transcriptional upregulated pro-inflammatory mediators affecting immune efficiency